Jeffrey Tom
TCI Peptide Therapeutics (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Monoclonal and Polyclonal Antibodies Research, Ubiquitin and proteasome pathways, Peptidase Inhibition and Analysis, Cell Adhesion Molecules Research
Most-Cited Works
- → A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease(2002)381 cited
- → A Designed Peptide Ligase for Total Synthesis of Ribonuclease A with Unnatural Catalytic Residues(1994)284 cited
- → Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation(2015)254 cited
- → Engineering subtilisin and its substrates for efficient ligation of peptide bonds in aqueous solution(1991)247 cited
- → Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)(2012)247 cited
- → The Coiled-coil Domain of Occludin Can Act to Organize Structural and Functional Elements of the Epithelial Tight Junction(2000)193 cited
- → Novel Peptides Selected to Bind Vascular Endothelial Growth Factor Target the Receptor-Binding Site(1998)190 cited
- → Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling(2020)169 cited
- → Identification of a Small Peptide That Inhibits PCSK9 Protein Binding to the Low Density Lipoprotein Receptor(2013)151 cited
- → Heterobifunctional Molecules Induce Dephosphorylation of Kinases–A Proof of Concept Study(2019)144 cited